However, the increased expression of tumor cell PD-L1 in S/R RCC tumors and the responsiveness of these tumors to PD-1 inhibitor monotherapy appeared to be independent of CD274 gene amplification (Fig. 4c and Supplementary Fig. S10a–c). The gene discussed is CD274; the disease is renal cell carcinoma.